# The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1

> **NCT05100186** · PHASE4 · UNKNOWN · sponsor: **Joseph Kavanagh, MD** · enrollment: 50 (estimated)

## Conditions studied

- Cataract

## Interventions

- **DRUG:** Dexamethasone 0.4 MG [Dextenza]

## Key facts

- **NCT ID:** NCT05100186
- **Lead sponsor:** Joseph Kavanagh, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-11-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-02-28
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2021-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100186, "The SITE Study - Dexamethasone Ophthalmic Insert In OR on Day of Surgery Versus In-office Post-Op Day 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05100186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*